This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2013 Mar;34(9):636-7.

doi: 10.1093/eurheartj/ehs432. Epub 2012 Dec 20.

New technologies, new therapies: toward personalized medicine in heart failure patients?

Pascal de Groote, Florence Pinet, Christophe Bauters

PMID: 23257952
DOI: 10.1093/eurheartj/ehs432

Editorial

New technologies, new therapies: toward personalized medicine in heart failure patients?

Pascal de Groote et al. Eur Heart J. 2013 Mar.

. 2013 Mar;34(9):636-7.

doi: 10.1093/eurheartj/ehs432. Epub 2012 Dec 20.

Authors

Pascal de Groote, Florence Pinet, Christophe Bauters

PMID: 23257952
DOI: 10.1093/eurheartj/ehs432

No abstract available

PubMed Disclaimer

Comment on

Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
Ameling S, Herda LR, Hammer E, Steil L, Teumer A, Trimpert C, Dörr M, Kroemer HK, Klingel K, Kandolf R, Völker U, Felix SB. Ameling S, et al. Eur Heart J. 2013 Mar;34(9):666-75. doi: 10.1093/eurheartj/ehs330. Epub 2012 Oct 25. Eur Heart J. 2013. PMID: 23100283 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems